Share Your Science workshop and write-a-thon, register by Feb. 20

The Share Your Science workshop and write-a-thon trains scientists to communicate scientific work to the public. If you want to make your research more accessible, this is a great opportunity. It...

OMSI looking for volunteer scientists for CRISPR event

OMSI is hosting a public forum on human applications of CRISPR gene editing technology. Participants will learn about genetic engineering and the related ethical and societal dimensions, along with...

Update regarding federal government shutdown

Updated Monday, Jan. 22 at 5 p.m.: The Senate and House have passed a continuing resolution to fund the government through Feb. 8. The shutdown will end once it is signed by President Trump with...

Advanced mapping and spatial reasoning tool for OHSU researchers

OHSU is providing licenses for ArcGIS, an advanced mapping and spatial reasoning tool. ArcGIS allows users to explore data and share location-based insights through a common visual language. The...

New NIH policy on electronic submission of diversity supplements

Effective January 25, 2018, the NIH will require all single and multi-project diversity supplement requests to be submitted electronically. This is a change in NIH policy, which currently uses paper...

Three questions for Alejandro Aballay

Alejandro Aballay, Ph.D., joined OHSU as chair of the Department of Molecular Microbiology and Immunology in September 2017. He came to OHSU from Duke University Medical Center, where he was...

OHSU Researchers: Core Pilot Funds – Update

Update 2 - December 1, 2017:  The University Shared Resources program would like to thank those who applied for FY2018 USR Pilot Fund Grants. They received nearly double the number of...

New treatment may address imatinib-resistant tumors

Each year, 3,000 to 6,000 people are diagnosed with gastrointestinal stromal tumor (GIST)—the most common sarcoma of the gastrointestinal tract. Imatinib myeslate, or Gleevec®, has proved to be a...